Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Expert Opin Investig Drugs. 2012 Mar 7;21(5):695–715. doi: 10.1517/13543784.2012.667072

Figure 2.

Figure 2

Tenofovir concentration distribution post single dose oral and topical vaginal administration. Adapted from Dumond et al, 2007 [43], Schwartz et al, 2011 [45]